Hepatic fibrosis is a condition characterized by the presence of scar tissue in the liver. It is the result of chronic inflammation caused by a variety of factors, including viral infections, alcohol consumption, and certain medications. Fibrosis is associated with a number of diseases, such as cirrhosis, liver cancer, and portal hypertension. The development of hepatic fibrosis is a complex process involving multiple cellular and molecular events. Initially, there is an infiltration of inflammatory cells into the liver. This triggers an inflammatory response, leading to the production of pro-inflammatory cytokines. These cytokines then activate the production of extracellular matrix molecules by hepatic stellate cells. As the extracellular matrix accumulates, it forms fibrous scar tissue, which can eventually lead to cirrhosis. In addition to the inflammatory process, other factors play a role in the development of hepatic fibrosis. Oxidative stress, which is an imbalance between free radicals and antioxidants, has been linked to liver fibrosis. In addition, elevated levels of cytokines and growth factors, as well as genetic factors, may also be involved.
Title : Gastroenterology viewed through a glass darkly: An IDI perspective
Gilles R G Monif, University of Florida, United States
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena, Italy
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, AUSL-ROMAGNA, Italy
Title : The IL17REL gene encodes a decoy receptor of IL-17 family cytokines to control gut inflammation
Youcun Qian, Shanghai Institute of Nutrition and Health, China